S. 2302 (119th)Bill Overview

Access to Birth Control Act

Health|Civil actions and liabilityDrug therapy
Cosponsors
Support
Democratic
Introduced
Jul 16, 2025
Discussions
Bill Text
Current stageIntroduced

Star Print ordered on the bill.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Plain-English summaryWhat this bill actually does

The Access to Birth Control Act amends the Public Health Service Act to require pharmacies that receive FDA-approved contraceptive products in interstate commerce to (1) provide in-stock contraceptives and related medications to customers without delay, (2) if out of stock but the pharmacy normally carries such items, immediately inform the customer and offer either a referral/transfer to a nearby pharmacy that has the item or expedited ordering, and (3) prohibit employee harassment, deception, confidentiality breaches, and withholding of lawful prescriptions. The bill exempts pharmacies that do not ordinarily stock contraceptives from the stocking/ordering requirement, allows refusals when dispensing would be unlawful, the customer cannot pay, or a professional clinical judgment supports refusal, and defines several terms (e.g., "without delay," "professional clinical judgment").

Why people may split

Treatment of religious/conscience claims: liberals view the RFRA limitation as necessary to protect access; conservatives view it as an unacceptable curtailment of religious liberty.

Watch point

Relative to its intended legislative type, this bill is a clearly articulated substantive policy change that provides specific operational duties, definitions, and enforcement tools, but it lacks administrative implementation detail and fiscal acknowledgment appropriate to the nationwide obligations and penalty regime it creates.

The Access to Birth Control Act amends the Public Health Service Act to require pharmacies that receive FDA-approved contraceptive products in interstate commerce to (1) provide in-stock contraceptives and related medications to customers without delay, (2) if out of stock but the pharmacy normally carries such items, immediately inform the customer and offer either a referral/transfer to a nearby pharmacy that has the item or expedited ordering, and (3) prohibit employee harassment, deception, confidentiality breaches, and withholding of lawful prescriptions.

The bill exempts pharmacies that do not ordinarily stock contraceptives from the stocking/ordering requirement, allows refusals when dispensing would be unlawful, the customer cannot pay, or a professional clinical judgment supports refusal, and defines several terms (e.g., "without delay," "professional clinical judgment").

It bars the Religious Freedom Restoration Act as a defense to covered claims, preserves state laws that provide greater customer protections, creates federal civil penalties (up to $1,000/day, $100,000 cap per proceeding) and a private right of action including actual and punitive damages and injunctive relief, and becomes effective 31 days after enactment.

Passage35/100

Content‑wise the bill is a focused statutory intervention that is administrable and supported by clear policy goals (improving access), but it addresses a highly politicized subject, creates exposure to federal civil enforcement and private litigation, and constrains conscience‑based defenses — features that historically attract intense opposition and make enactment more difficult at the federal level. The absence of spending commitments or complex rulemaking reduces some implementation barriers, but the political and legal flashpoints reduce the bill’s chances of becoming law based on content alone.

CredibilityPartially aligned

Relative to its intended legislative type, this bill is a clearly articulated substantive policy change that provides specific operational duties, definitions, and enforcement tools, but it lacks administrative implementation detail and fiscal acknowledgment appropriate to the nationwide obligations and penalty regime it creates.

Contention70/100

Treatment of religious/conscience claims: liberals view the RFRA limitation as necessary to protect access; conservatives view it as an unacceptable curtailment of religious liberty.

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
Likely helpedLikely burdened

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • Potential benefitIncreased and more timely access to FDA-approved contraceptives and related medications at retail pharmacies, likely re…
  • Potential benefitPotential public health benefits from improved contraceptive access, such as reductions in unintended pregnancies and r…
  • Potential benefitStronger protections for patient privacy and against harassment or misinformation at pharmacies when requesting contrac…
Likely burdened
  • Potential burdenAdds regulatory compliance costs and administrative burdens for pharmacies (especially small or rural ones) to track st…
  • Potential burdenIncreases legal exposure for pharmacies through daily civil penalties and a broad private right of action that could le…
  • Potential burdenLimits the applicability of the Religious Freedom Restoration Act as a defense for pharmacies or employees, which criti…
03 · Why people split

Why the argument around this bill splits.

Treatment of religious/conscience claims: liberals view the RFRA limitation as necessary to protect access; conservatives view it as an unacceptable curtailment of religious liberty.
Progressive90%

A mainstream liberal would likely view the bill as a strong, necessary federal measure to protect and expand access to contraception and to limit discriminatory denials at pharmacies.

They would appreciate the direct, enforceable duties on pharmacies, the private right of action, and the prohibition on using RFRA to block enforcement.

They might note the bill focuses on dispensing and referrals rather than insurance coverage, and see it as a practical response to post-Dobbs access disruptions.

Leans supportive
Centrist65%

A mainstream centrist would likely be cautiously supportive of the bill's objective to reduce access barriers to contraception but concerned about operational details and unintended consequences.

They would welcome clear rules for when pharmacies must fill or refer and the emphasis on preventing harassment, while wanting clearer definitions and predictable, proportionate enforcement.

They would view private lawsuits and daily civil penalties as useful accountability tools but worry about excessive litigation risk or burdens on small businesses without transition help.

Split reaction
Conservative15%

A mainstream conservative would likely view the bill as federal overreach into pharmacy practice that interferes with conscience and religious liberty, especially because the bill explicitly removes RFRA as a defense to claims under the covered title.

They would be concerned about mandatory duties, potentially heavy civil penalties and private lawsuits, and the imposition of uniform federal standards on pharmacies that are typically regulated at the state level.

While acknowledging the goal of ensuring access to contraception, they would argue the bill insufficiently protects employee and pharmacy conscience rights and could impose burdens on small, faith-based, or rural pharmacies.

Likely resistant
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Still ahead

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood35/100

Content‑wise the bill is a focused statutory intervention that is administrable and supported by clear policy goals (improving access), but it addresses a highly politicized subject, creates exposure to federal civil enforcement and private litigation, and constrains conscience‑based defenses — features that historically attract intense opposition and make enactment more difficult at the federal level. The absence of spending commitments or complex rulemaking reduces some implementation barriers, but the political and legal flashpoints reduce the bill’s chances of becoming law based on content alone.

Scope and complexity
52%
Scopemoderate
24%
Complexitylow
Why this could stall
  • Level of cross‑chamber political support and willingness to prioritize a contested reproductive‑access measure in a given legislative calendar is unknown and pivotal.
  • Potential legal challenges not predictable from the text (e.g., constitutional claims or state‑federal preemption disputes) could affect enforceability and stakeholder support.
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Treatment of religious/conscience claims: liberals view the RFRA limitation as necessary to protect access; conservatives view it as an una…

Content‑wise the bill is a focused statutory intervention that is administrable and supported by clear policy goals (improving access), but…

Unlocked analysis

Relative to its intended legislative type, this bill is a clearly articulated substantive policy change that provides specific operational duties, definitions, and enforcement tools, but it lacks administrative implemen…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis